Order results by:
Issue | Title | |
Vol 18, No 2 (2025) | Cosmetics as a product group of the Russian pharmaceutical market: analysis of competition and level of dominance | Abstract similar documents |
N. I. Markov, L. S. Treshchetkina | ||
"... ) cosmetics. Material and methods. The study was based on annual reports on the Russian pharmaceutical market ..." | ||
Vol 16, No 4 (2023) | Sales of antitumor drugs in the retail segment of the Russian pharmaceutical market | Abstract similar documents |
I. K. Petrukhina, T. K. Ryazanova, E. P. Gladunova, A. M. Lazarev, A. A. Krivova | ||
"... at the expense of personal funds of citizens in the retail sector of the pharmaceutical market of the Russian ..." | ||
Vol 15, No 1 (2022) | The analysis of the consumption level of antihypertensive drugs and statins in a retail pharmacy of the Samara Region in 2015–2020 | Abstract similar documents |
I. K. Petrukhina, P. A. Lebedev, E. P. Gladunova, T. K. Ryazanova, A. A. Garanin, P. R. Blinkova | ||
"... market of the Samara Region in 2015–2020 was carried out. The material of this retrospective study ..." | ||
Vol 12, No 2 (2019) | Dynamics of prices and consumption of anticancer drugs in Russia after their generics and biosimilars became available | Abstract similar documents |
F. V. Gorkavenko, A. V. Nikitina, E. S. Saibel’, M. V. Avksent’eva, M. V. Sura, D. V. Fedyaev | ||
"... Since generics and biosimilars have entered the Russian market of medications, there are new ..." | ||
Vol 15, No 2 (2022) | The current state of the veterinary drugs market in the Tyumen Region | Abstract similar documents |
V. V. Byshenko, О. I. Knysh, L. N. Zadirachenko, А. О. Egorova, Yu. S. Rodina | ||
"... Objective: to assess the current state of the veterinary medical product market in the Tyumen ..." | ||
Vol 10, No 4 (2017) | THE INTERNATIONAL PRACTICE OF DRUG SUPPLY IN THE OUTPATIENT SEGMENT | Abstract similar documents |
D. V. Lukyantseva, L. S. Mel’nikova, A. P. Tatarinov | ||
"... возможностью сооплаты пациентами лекарственных препаратов в амбулаторном сегменте. ..." | ||
Vol 18, No 2 (2025) | Marketing analysis of the Russian pharmaceutical market for treatment of neovascular age-related macular degeneration | Abstract similar documents |
F. V. Gorkavenko, A. B. Goryachev, O. V. Ashikhmina, D. V. Fedyaev, N. V. Ignateva, E. A. Smolyarchuk, A. V. Kirchenko, D. D. Tkachenko, V. I. Brazhnikova | ||
"... of the market for angiogenesis inhibitors used in the treatment of neovascular age-related macular degeneration ..." | ||
Vol 5, No 1 (2012) | MODERNIZATION OF THE MEDICAL SERVICES MARKET | Abstract similar documents |
A. U. Kulikov | ||
"... The necessity of modernization of the medical services market, which requires its structural ..." | ||
Vol 6, No 3 (2013) | THE ANALYSIS OF THE MARKET OF PHARMACEUTICALS FOR DYSMENORRHEA TREATMENT | Abstract similar documents |
N. Yu. Cherkasova, A. V. Fomina, O. V. Filippova | ||
"... The range and sales analysis of pharmaceuticals for the dysmenorrhea treatment on the market ..." | ||
Vol 12, No 3 (2019) | Clinical and economic analysis as an instrument for harmonizing import substitution in the preferential segment of medicinal support | Abstract similar documents |
E. V. Eliseeva , E. S. Maneeva , R. K. Goncharova , A. V. Kropotov | ||
"... предоставления рекомендаций по повышению роли отечественных аналогов в льготном сегменте. Материалы и методы ..." | ||
Vol 7, No 2 (2014) | THE ANALYSIS OF THE LIPETSK PHARMACEUTICAL MARKET OF NASAL GLUCOCORTICOSTEROID | Abstract similar documents |
K. V. Danilova, I. M. Razdorskaya | ||
"... to the analysis of the local market, which allowed us to elicit the main trends and peculiarities ..." | ||
Vol 17, No 1 (2024) | Compounding pharmacy regulations: experience of the Latvian pharmaceutical market | Abstract similar documents |
D. D. Mamedov, D. S. Yurochkin, D. D. Zelikova, S. E. Erdni-Garyaev, Z. M. Golant, I. A. Narkevich | ||
"... pharmaceutical market to improve approaches for statutory regulation of this special and socially significant ..." | ||
Vol 17, No 4 (2024) | Biologically active supplements: safety, efficacy, market review | Abstract similar documents |
A. M. Stepanova, А. N. Plutnitskiy, E. V. Gameeva | ||
"... and safety of BAS, as well as the market for such products. The presented data underscore the risks ..." | ||
Vol 18, No 1 (2025) | Reorganization of public procurement of biosimilars and its economic effect on the monoclonal antibody market in Russia | Abstract similar documents |
A. Yu. Efremov, A. M. Vlasov, V. I. Gegechkori, N. V. Gorpinchenko, G. V. Ramenskaya, T. M. Litvinova | ||
"... ) is altering the structure of the pharmaceutical market by amplifying the share of domestic manufacturers ..." | ||
Vol 16, No 1 (2023) | Compounding pharmacy regulations: experience of the North American pharmaceutical market | Abstract similar documents |
D. D. Mamedov, D. S. Yurochkin, A. A. Leshkevich, S. E. Erdni-Garyaev, Z. M. Golant, I. A. Narkevich | ||
"... of the compounding pharmacy regulation in North American pharmaceutical market. The main imperatives are identified ..." | ||
Vol 17, No 3 (2024) | Biologically active supplements overview: regulation, market trends, application, and health impact | Abstract similar documents |
A. M. Stepanova, A. N. Plutnitskiy, E. V. Gameeva | ||
"... and the corresponding market trends, including a comprehensive analysis of the legislative and regulatory aspects of BAS ..." | ||
Vol 16, No 4 (2023) | Investigating the current state of the Russian market for drugs treating infectious and inflammatory conditions of oral cavity and oropharynx to demonstrate the need for new drug development | Abstract PDF (Eng) similar documents |
V. I. Zvereva, D. R. Dzhavakhyan, V. N. Dul, V. S. Bobyleva, A. A. Markaryan, E. I. Morkovin, D. V. Kurkin, M. A. Dzhavakhyan | ||
"... Objective: to assess the relevance and commercial prospects of bringing to market a drug ..." | ||
Vol 15, No 1 (2022) | Study of methods for state regulation of prices and costs of the health care system for medicines in the United Kingdom | Abstract similar documents |
A. A. Leshkevich, D. S. Yurochkin, Z. M. Golant, I. A. Narkevich | ||
"... market access for new therapies. As practice shows, the Voluntary Scheme is more profitable for most ..." | ||
Vol 15, No 4 (2022) | Analysis of the main indicative values of the pharmaceutical market retail sectors in the constituent entities of the Russian Federation | Abstract similar documents |
I. К. Petrukhina, Т. К. Ryazanova, А. I. Khusainova, А. V. Egorova, P. R. Blinkova | ||
"... Objective: to study various typological characteristics of the retail pharmaceutical market sector ..." | ||
Vol 18, No 1 (2025) | The sale of medicines used for diabetes mellitus treatment in retail segment of Russian pharmaceutical market | Abstract similar documents |
I. K. Petrukhina, A. M. Lazarev, T. K. Ryazanova, P. A. Lebedev, E. P. Gladunova, G. T. Glembotskaya | ||
"... for the treatment of diabetes mellitus (DM), sold in the retail sector of the pharmaceutical market of the Russian ..." | ||
Vol 13, No 2 (2020) | Review of calculation methods, procedures for registration and re-registration of producer prices of medicines in the countries of the Eurasian Economic Union | Abstract similar documents |
A. A. Leshkevich, D. S. Yurochkin, Z. M. Golant, I. A. Narkevich | ||
"... formation is an essential condition for the functioning of the united market of pharmaceutical drugs. ..." | ||
Vol 14, No 2 (2021) | Analysis of the availability and affordability of pharmaceuticals for children in need of palliative care | Abstract similar documents |
D. M. Medvedeva, I. A. Narkevich, O. D. Nemyatykh | ||
"... had the lowest physical availability scores (LDI<3%) in the Russian market compared to the relatively ..." | ||
Vol 17, No 2 (2024) | Mathematical modeling and analysis of export trends for certain pharmaceutical groups | Abstract similar documents |
А. R. Shaikhislamova, N. А. Gasratova | ||
"... market. The obtained results can be useful for developing strategies of the pharmaceutical industry ..." | ||
Vol 18, No 1 (2025) | Problems of using phenol (hydroxybenzene) and parabens as pharmaceutical stabilizers: analysis using machine learning methods | Abstract similar documents |
I. Yu. Torshin, O. A. Gromova | ||
"... toxicity tests) and are used in pharmaceutical, cosmetic and food industries as stabilizers/preservatives ..." | ||
Vol 11, No 4 (2018) | Costs of pharmacotherapy in pediatric patients with community-acquired pneumonia: mathematical and statistical analysis | Abstract similar documents |
I. A. Narkevich, O. D. Nemyatyh, D. D. Siukaeva, I. V. Pavlushkov, D. O. Ivanov, Ya. V. Panyutina | ||
"... наименований назначенных лекарственных препаратов, количество пораженных сегментов, локализация возбудителя ..." | ||
Vol 15, No 1 (2022) | Pharmacoepidemiological analysis of medication consumption in a multidepartmental hospital as an element of medical care quality management and the basis for assessing import substitution | Abstract similar documents |
O. V. Zhukova, O. V. Ruina, M. V. Khazov, T. M. Konyshkina, E. A. Rodin, D. K. Lipatov | ||
"... различные фармакотерапевтические группы ЛП в двух сегментах (отечественное и зарубежное производство) в ..." | ||
Vol 17, No 1 (2024) | A clinical case of ectopic pregnancy with localization in the liver | Abstract similar documents |
A. Е. Voynovskiy, О. A. Zaitseva, A. G. Solopova, D. V. Blinov, М. P. Malykh-Bakhtina, G. К. Bykobshchenko | ||
"... лапароскопическая операция, в ходе которой обнаружено плодное яйцо в V сегменте печени. Выполнена резекция печени и ..." | ||
Vol 8, No 2 (2015) | PRINCIPLES OF IMPORT SUBSTITUTION REGARDING DRUGS | Abstract similar documents |
Alana Viktorovna Dzaneva, Vitalii Vladimirovich Omel'yanovskii, Saniyat Aleksandrovna Kagermazova | ||
"... products at the domestic market of the country. ..." | ||
Vol 14, No 4 (2021) | Features of intellectual property protection mechanisms on the example of orphan drugs circulation | Abstract similar documents |
D. S. Yurochkin, К. V. Nasonova, Z. М. Golant, I. А. Narkevich, V. P. Trukhin | ||
"... market data was performed with the DSM Group analytical database. The approach proposed by the Russian ..." | ||
Vol 8, No 4 (2015) | PLANNING OF EXTENT AND FINANCIAL EXPENSES FOR DELIVERY OF HEALTH CARE IN HOSPITALS AT THE FEDERAL AND REGIONAL LEVELS | Abstract similar documents |
M. V. Sura | ||
"... объема медицинской помощи и финансовых затрат, включая стационарный сегмент. За последние годы ..." | ||
Vol 15, No 2 (2022) | Current opportunities for the export of medical services in Russia | Abstract similar documents |
S. V. Russkikh, E. A. Tarasenko, S. I. Grin, M. T. Yugay, K. K. Kryukova, L. I. Moskvicheva | ||
"... foreign citizens in the medical services market are developing: 1) creating expert medical consortia ..." | ||
Vol 14, No 2 (2021) | Impact of disease information (Ebola and COVID-19) on the pharmaceutical sector in Russia and USA | Abstract similar documents |
E. A. Fedorova, D. O. Afanasyev, A. V. Sokolov, M. P. Lazarev | ||
"... , but also after: there is a "delayed effect". Ebola news affects the American pharmaceutical market for 2 ..." | ||
Vol 17, No 4 (2024) | Regional aspects of availability of expectorants and antitussive drugs | Abstract similar documents |
V. М. Timiryanova, А. V. Samorodov, Z. А. Valiullina, V. B. Prudnikov, D. Kh. Krasnoselskaya | ||
"... of market responses to external shocks and government-developed mechanisms for stabilizing markets ..." | ||
Vol 14, No 1 (2021) | Analysis of acquisition and the monthly cost of antihypertensive therapy with modern fixed-dose combinations in the Far Eastern Federal District | Abstract similar documents |
M. S. Soboleva, E. E. Loskutova | ||
"... ценовом сегменте 500–1000 руб. Предпочтения при применении сочетаний блокаторов рецепторов ангиотензин ..." | ||
Vol 12, No 2 (2019) | Recent changes in the pharmacovigilance system in the Russian Federation and the EAEU | Abstract similar documents |
G. N. Gildeeva, A. V. Belostotsky | ||
"... . The current practice of pharmacovigilance in the EAEU is of interest to potential foreign investors and market ..." | ||
Vol 15, No 1 (2022) | Cost-effectiveness and budget impact analyses of using implantable cardioverter-defibrillators in the Russian Federation | Abstract similar documents |
T. O. Bessonova, F. V. Gorkavenko, D. G. Shchurov, Yu. V. Seryapina, O. R. Chetverikova, V. V. Omelyanovskiy, S. N. Krivolapov, N. M. Neminushchiy, A. A. Kalemberg | ||
"... сценарии составил 2,8 и 2,2 млн руб. в сегментах первичной и вторичной профилактики ВСС соответственно ..." | ||
Vol 7, No 2 (2014) | CLINICAL AND ECONOMIC EVALUATION OF IVABRADINE USE IN STABLE ANGINA IN TERMS OF REPUBLIC OF BELARUS HEALTH CARE SYSTEM | Abstract similar documents |
I. N. Kozhanova, I. S. Romanova, L. N. Gavrilenko, A. V. Patseev, M. M. Sachek | ||
"... , national surveillance data, local health services market and cardiovascular drugs market estimation. “Cost ..." | ||
Vol 9, No 2 (2016) | BUDGET IMPACT ANALYSIS OF PERAMPANEL FOR ADJUNCTIVE TREATMENT IN EPILEPSY PATIENTS 12 YEARS OF AGE AND OLDER FOR PARTIAL ONSET SEIZURES WITH OR WITHOUT SECONDARY GENERALIZATION AND PRIMARY GENERALIZED TONIC-CLONIC SEIZURES IN THE RUSSIAN FEDERATION | Abstract similar documents |
V. R. Mkrtchyan, A. M. Sergeev, K. I. Pochigaeva, I. A. Shpak | ||
"... Adoption). In the latter scenario, market share of perampanel was assumed to increase every year for up ..." | ||
Vol 12, No 3 (2019) | Availability and Pharmacoeconomics of Insulin Therapy in Countries with the Largest Number of Diabetics | Abstract PDF (Eng) similar documents |
S. V. Ponomarenko | ||
"... in the Internet. The demand and supply in the market of recombinant therapeutic insulin, the insulin market ..." | ||
Vol 13, No 2 (2020) | Affordability of in vivo gene therapy. Problems and potential solutions | Abstract similar documents |
V. V. Omelyanovskiy, N. Z. Musina, V. A. Lemeshko, A. A. Antonov, F. V. Gorkavenko | ||
"... pharmaceutical market. The analysis of the methodology used in the found CESs was performed based on the given ..." | ||
Vol 10, No 3 (2017) | ABC-analysis of pharmacotherapy in children hospitalized with bronchial asthma exacerbations | Abstract similar documents |
O. V. Zhukova, S. V. Kononova | ||
"... определенную долю в сегменте А занимают антибиотики макролидного ряда группы азитромицина (на них приходится 5 ..." | ||
Vol 13, No 3 (2020) | Comparative analysis of antipsychotic drug consumption for inpatient schizophrenia treatment: a retrospective study with 5-year follow-up | Abstract similar documents |
L. B. Vaskova, M. V. Tiapkina, E. V. Mikhaylenko | ||
"... %-сегмент (49,04 и 45,26 NDDD/100 койко-дней в 2017 г. соответственно). Кроме того, отмечены высокая ЧН и ..." | ||
Vol 18, No 1 (2025) | Trends in the industry of clinical trials | Abstract similar documents |
S. S. Milovanov, V. V. Popov, N. V. Teplova | ||
"... русскоязычном и англоязычном сегментах сети Интернет в источниках с открытым доступом в базах данных ..." | ||
Vol 17, No 4 (2024) | Pharmacoeconomic study of active psoriatic arthritis treatment | Abstract similar documents |
A. V. Rudakova, Т. V. Korotaeva | ||
"... on the pharmaceutical market of the Russian Federation. Material and methods. The evaluation of clinical and economic ..." | ||
Vol 12, No 3 (2019) | Pharmacoepidemiological analysis of antimicrobial therapy for burn injury in the hospital settings | Abstract similar documents |
O. V. Zhukova, E. S. Nekaeva, E. S. Khoroshavina, E. A. Kozlova, Yu. A. Dudukina, I. Yu. Arefyev | ||
"... составляют 83,33% в реальной структуре назначения. Показатели стоимости одной DDD в сегменте DU10% и DU90 ..." | ||
Vol 12, No 4 (2019) | Optimization of drug supply for patients with malignant neoplasms in a region of the Russian Federation | Abstract similar documents |
A. V. Nikitina, F. V. Gorkavenko, Y. S. Saybel, M. V. Avxentyeva, M. S. Sura, D. V. Fedyaev | ||
"... to the level identified in a previous retrospective analysis of the pharmaceutical market. The baseline ..." | ||
Vol 15, No 3 (2022) | Review of international practice of health care provider network planning | Abstract similar documents |
V. V. Omelyanovskiy, D. V. Lukyantseva, N. N. Sisigina | ||
"... market based on the rest of the Compulsory Health Insurance program. Conclusion. Current Russian health ..." | ||
Vol 14, No 2 (2021) | Pharmacoeconomic aspects of the therapy for moderate and severe psoriatic arthritis | Abstract similar documents |
A. V. Rudakova, D. G. Tolkacheva, V. D. Sokolova | ||
"... and a biosimilar registered on the pharmaceutical market, the calculation was based on the median of the registered ..." | ||
Vol 13, No 2 (2020) | Biological effects of phytoestrogens: clinical effectiveness and potential application in the treatment of climacteric syndrome | Abstract similar documents |
M. A. Chernyavskaya, I. A. Narkevich | ||
"... on the market, they must meet high safety requirements. ..." | ||
Vol 14, No 4 (2021) | Application of medical products: mandatory requirements, supervision of their compliance | Abstract similar documents |
O. A. Makhova | ||
"... and implementation in healthcare require post-market control and safe use. Objective: to study the existing state ..." | ||
1 - 50 of 54 Items | 1 2 > >> |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)